Announcement on Preliminary Earnings Estimate for 2025
Filed with SSE · · 3 pages · Chinese
Xiamen Amoytop Biotech Co., Ltd. on 6ix
Earlier from Xiamen Amoytop Biotech
- Announcement on Voluntary Disclosure of a Wholly-owned Subsidiary Passing the High and New Technology Enterprise Certification
- XIAMEN AMOYTOP BIOTECH CO., LTD. Announcement on Obtaining Notice of Approval for Drug Clinical Trial of ACT100 for Injection
- Announcement on Voluntary Disclosure of Recognition of the Ninth Batch of National-level Manufacturing Single-Item Champion Enterprises
- Indicative Announcement on Disclosure of Proposal for Issuing Convertible Corporate Bonds to Non-specific Objects
- Announcement on Actual Controller Renewing the Concerted Action Agreement
Later from Xiamen Amoytop Biotech
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on the Chairman's Proposal to Repurchase Shares
- Announcement on Amending Articles of Association and Some Governance Systems
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Convening the 2025 Annual Performance and Cash Dividend Briefing
Follow Xiamen Amoytop Biotech into a list and get an email when it puts out news.
Follow Xiamen Amoytop Biotech